NEPHRODI THERAPEUTICS
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.
NEPHRODI THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.nephrodi.com
Total Employee:
1+
Status:
Active
Contact:
206-696-0546
Total Funding:
1.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Rasio Therapeutics
Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology.
Reiley Pharmaceuticals
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer and infectious diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Neurolixis
Neurolixis is a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders.
NMB Therapeutics
NMB Therapeutics is a pharmaceutical company that develops products to provide efficient drug delivery.
Vector Vitale
Vector Vitale is creating therapeutic solutions that provide symmetry correction of biomolecules.
Vincerx Pharma
Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.
Verastem Oncology
Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.
Melior Discovery
Melior Discovery offers a pharmacology platform to identify novel indications for pre-clinical development stage drug candidates.
Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases
MindImmune Therapeutics
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
Lymphact
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments.
Leiters
Leiters is a pharmaceuticals company that offers compounding medication services.
Laboratoire PhytoChemia inc
PhytoChemia inc is an expert in plant chemistry and offers standardization and chemical quality control solutions for plant based products.
Allecra Therapeutics
Allecra is a biopharmaceutical company focused on the development of novel treatments to combat multi-drug-resistant bacterial infections.
Abveris
Abveris is a biotechnology company that specializes in the discovery of antibodies for reagent and therapeutic purposes.
Allterum Therapeutics
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.
Atropos Therapeutics
Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer.
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
AptaTargets
AptaTargets is a biopharmaceutical company focused in developing therapeutic
Animal Bioscience
Animal Bioscience is a pet platform.
Ancora Pharmaceuticals
Ancora Pharmaceuticals, Inc., a biopharmaceutical company, develops immune system modulation therapeutics using synthetic carbohydrates in
Eyetech Pharmaceuticals
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye.
Bridge Therapeutics
Bridge Therapeutics is a pharmaceutical company.
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
BioVidria
BioVidria is a biotech company that focuses on new materials for protein analysis to advance pharmaceuticals, proteomics, and agriculture.
Biogelx
Biogelx is a biomaterials company which designs and supplies peptide hydrogels for cell culture.
Formulary Insights
Formulary Insights help biopharmaceutical investors, marketers, and leaders understand and anticipate payer perceptions of their product.
TFF Pharmaceuticals
TFF Pharmaceuticals is a clinical-stage biopharmaceutical company that develops drug products.
TALON THERAPEUTICS
Talon Therapeutics is a biopharmaceutical company offering products for clinical development.
Tanvex BioPharma
Tanvex BioPharma is a biopharmaceutical company that provides drug manufacturing, sales, and distribution services.
Theriana Pharmaceuticals
Theriana Pharmaceuticals, Inc. manufactures pharmaceuticals
Teon Therapeutics
Teon Therapeutics is a a biopharmaceutical company developing small molecules that inhibit the immunosuppressive cancer signaling pathways.
KeifeRx
KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.
KeChow Pharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
101 Therapeutics
101 Therapeutics is a clinical stage pharma company curing infectious diseases by targeting the pathology not the the pathogen.
SparX Therapeutics
SparX Therapeutics is a biopharmaceutical firm that develops smart drug technology for anti-cancer and anti-tumor treatment therapy.
Samsara Therapeutics
Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
Santi Therapeutics
Santi Therapeutics is a pharmaceutical company that focuses on the research and development of small molecule therapeutics.
Dyax
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet
Dunad Therapeutics
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
DiaKine Therapeutics
DiaKine Therapeutics is a development stage company commercializing novel immune modulators for the treatment of diabetes.
Hope Biosciences
Hope Biosciences is a biopharmaceutical company that offers mesenchymal stem cell culture products and services for adults and newborns.
HTBT
HTBT is a biopharmaceutical manufacturer that focuses on international biotechnology introduction and absorption.
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
iReprogram
iReprogram is a cell regeneration lab that aims to expedite the delivery of next-generation personalized medicine.
Glionova
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
CVasThera
CVasThera is a biopharmaceutical company that specializes in the development of novel therapies for cardiovascular and bowel pathologies.
Chamishi Therapeutics
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.
Coqui Radio Pharmaceuticals
Coqui Radio Pharmaceuticals is a biopharmaceutical company that manufactures and supplies medical diagnostic and therapeutic radioisotopes.
CyDex Pharmaceuticals
CyDex Pharmaceuticals is a pharmaceutical company that engages in the development and commercialization of drugs specifically designed.
Cipherome
Cipherome is a biotech company that finds the drug that works for each individual.
Cortene
Cortene is a clinical-stage biopharmaceutical company focused on developing treatments for chronic fatigue syndrome and other diseases.
Compass Therapeutics, Inc.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Prokaryotics
Prokaryotics is a biopharmaceutical company focused on the discovery and development of novel antibiotic classes.
Polaris Pharmaceuticals
Polaris Pharmaceuticals is a multinational biotechnology company focused on developing novel anti-cancer therapies.
Pharmula Laboratories
Pharmula Laboratories is a start-up company for New Drug and ANDA pharmaceutical product development.
Current Employees Featured
Founder
More informations about "NephroDI Therapeutics"
NephroDI Therapeutics
NephroDI Therapeutics is a pharmaceutical company focusing on concentration disorders of the kidney. NephroDI is initially developing an oral drug to treat Nephrogenic Diabetes Insipidus …See details»
About Us | NephroDI Therapeutics
NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI). The genesis of this technology began with Drs. Jeff …See details»
NDI Foundation - for the cure of Nephrogenic …
Our goal is to create a communication channel to serve the entire NDI community: patients and their families, researchers, physicians and other health care providers. Learn more about the diagnosis, history, and treatment of …See details»
The Team | NephroDI Therapeutics
Rachael Hagan is a recognized leader with a demonstrated track record of commercializing early-stage technology out of universities. Ms. Hagan is experienced in promoting emerging …See details»
NephroDI Therapeutics Company Profile 2024: …
Information on valuation, funding, cap tables, investors, and executives for NephroDI Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
NephroDI Therapeutics Announces Four New Leadership Team …
Sep 8, 2023 · SEATTLE, WASHINGTON, UNITED STATES, September 8, 2023/EINPresswire.com/ -- NephroDI Therapeutics (NephroDI), a pharmaceutical company …See details»
NephroDI Therapeutics Enters Agreement to Develop a First-in …
Jun 22, 2023 · NephroDI Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, focused on developing and commercializing a class of novel kidney …See details»
Xontogeny Seeds NephroDI to Develop a Treatment …
May 12, 2021 · NephroDI Therapeutics received seed investment from investment firm and incubator Xontogeny to advance its lead therapeutic for the X-linked/congenital form of nephrogenic diabetes insipidus through preclinical …See details»
NephroDI Therapeutics Strikes Deal for Revolutionary Kidney …
Jun 23, 2023 · NephroDI Therapeutics, a Biolocity portfolio company, has made waves in the medical field with its recent agreement to develop a first-in-class treatment for a rare genetic …See details»
Sound Bioventures invests in US company NephroDI Therapeutics
Jun 24, 2024 · NDI-5001 is a proprietary small molecule AMPK activator that targets the kidney and is a potential first-in-class treatment for Congenital Nephrogenic Diabetes Insipidus (NDI), …See details»
News | NephroDI Therapeutics
NephroDI Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, focused on developing and commercializing drugs to treat concentration disorders of the kidney.See details»
NephroDI Therapeutics, MSRD partner to develop therapy for NDI
Jun 23, 2023 · NephroDI Therapeutics has signed a deal with the McQuade Center for Strategic Research and Development (MSRD), a member of the global Otsuka group of pharmaceutical …See details»
NephroDI Therapeutics Lands Financing to Develop a Treatment …
May 12, 2021 · NephroDI’s lead product, NDI-5033 is a unique adenosine monophosphate activated kinase (AMPK) activator that can stimulate water reabsorption without causing …See details»
NephroDI Therapeutics Lands Financing to Develop a Treatment …
May 12, 2021 · NephroDI’s lead product, NDI-5033 is a unique adenosine monophosphate activated kinase (AMPK) activator that can stimulate water reabsorption without causing …See details»
NephroDI Therapeutics Enters Agreement to Develop a First-in …
Jun 23, 2023 · MSRD at Otsuka in the U.S. and NephroDI will collaborate with respect to the clinical development of NephroDI’s asset, NDI-5001, a novel kidney-targeted small molecule …See details»
NephroDI Therapeutics Announces Investment by Sound
Jun 20, 2024 · NephroDI Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, focused on developing and commercializing drugs to treat concentration …See details»
NephroDI Therapeutics Announces Investment by Sound …
Jun 20, 2024 · NephroDI Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, focused on developing and commercializing drugs to treat concentration …See details»
NephroDI Therapeutics Announces Investment by Sound …
Jun 20, 2024 · Together with a previously announced strategic corporate partnership, the capital will be used to advance NDI-5001, a proprietary small molecule AMPK activator that targets …See details»
FAQ & Resources | NephroDI Therapeutics
NephroDI proposes to initially develop its first product to address X-linked NDI caused by a mutation on the vasopressin V2 receptor (AVPR2) gene. Based on preclinical studies, the first …See details»
NephroDI Therapeutics Announces Investment by Sound …
Jun 20, 2024 · The company’s lead program is NDI-5001, a novel kidney-targeted small molecule AMPK activator being developed as a potential first-in-class treatment of Congenital …See details»